Navigation Links
Triple-S Management Corporation Schedules Fourth-Quarter and Year-End Earnings Release and Webcast
Date:1/27/2009

lth insurance and the fourth largest provider of property and casualty insurance in its market.

For more information about Triple-S Management, visit http://www.triplesmanagement.com.


'/>"/>
SOURCE Triple-S Management Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Triple-S Management Corporation Announces Conversion of Class A Shares and Commencement of Class B Stock Repurchase Program
2. Triple-S Management Corporation Signs Letter of Intent to Acquire Managed Care Portfolio of La Cruz Azul de Puerto Rico, Inc.
3. Triple-S Management Corporation to Present at Credit Suisse 2008 Healthcare Conference
4. Triple-S Management Corporation Reports Third Quarter 2008 Results; Board Approves Share Repurchase Authorization of up to $40 Million
5. Triple-S Management Corporation Schedules Second-Quarter Earnings Release and Webcast
6. Triple-S Management Corporation Reports First Quarter 2008 Results; Cites Growth Resulting From Strong Market Position
7. Triple-S Management Corporation Schedules First-Quarter Earnings Release and Webcast
8. Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007
9. Triple-S Management Corporation to Present at UBS Global Healthcare Conference
10. Triple-S Management Corporation Announces Full Exercise of Underwriters Over-Allotment Option
11. Sierra Tucson Pain Management Program Awarded Pain Program Accreditation by the American Academy of Pain Management For Treatment of Chronic Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2014)... orphaned by HIV/AIDS in South Africa may provide insight ... behavior issues in other areas of the world, which ... that could lead to successful interventions. , A ... United Nations mentions that due to the HIV/AIDS pandemic, ... African, children are at an increased risk for mental ...
(Date:4/14/2014)... A new study shows that moderate to severe ... risk of stroke, cancer and death. , Results of ... to severe obstructive sleep apnea were four times more ... times more likely to have a stroke (HR = ... (HR = 3.4), and 2.5 times more likely to ...
(Date:4/14/2014)... Dallas study involving serious youth offenders, the answer to one ... seven years: "How long do you think you,ll live?", According ... offending over time., Author Dr. Alex Piquero said the study ... of them offend at very high rates and commit more ... much later in life offend much less., "In a lot ...
(Date:4/14/2014)... with symptoms increasing dramatically during some of the most important ... has found. , Depressive symptoms increased on average by 68 ... young men, who were around 25 years old when they ... their children. The results of the study were published April ... is the first to identify when young fathers are at ...
(Date:4/14/2014)... Lower weight babies and babies who aren,t breastfed ... risk of developing chronic inflammation and related health ... study. , "There were good reasons to hypothesize ... inflammation in adulthood," says Thomas McDade (Northwestern University), ... in the Child & Brain Development program. "It ...
Breaking Medicine News(10 mins):Health News:Researchers identify children with emotional behavior difficulties 2Health News:Researchers identify children with emotional behavior difficulties 3Health News:Study links severe sleep apnea to increased risk of stroke, cancer and death 2Health News:UT Dallas study: Youth who fail to envision future commit more crimes 2Health News:Young dads at high risk of depression, too 2Health News:Low birth weight, less breastfeeding create later health risks 2
... , , , , ... (Nasdaq: WCRX ) today announced its results for the ... 30, 2009 increased 7.1% to $250.8 million over the prior year ... net sales of DORYX, LOESTRIN 24 FE and ESTRACE Cream which ...
... - Quarter Marked by Launch of RYZOLT(TM) in U.S. -, ... Novel Trazodone, ... , , LAVAL, QC, Aug. 7 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: ... figures are in Canadian dollars unless otherwise stated. , "The second quarter of 2009 was highlighted ...
... ... and technology solutions, today announced the opening of a Chicago field office to better support ... ... Marathon Health, a leading provider of onsite employee health services and technology solutions, ...
... ... vice president for consulting. , ... St. Louis, MO (Vocus) -- Navvis & Company announces the appointment ... the firm and its clients extensive experience and expertise in health system operations, strategic ...
... expensive patients need fewer health care resources and cost insurers ... care team that tracks their health and offers regular support, ... Bloomberg School of Public Health. The research, published in the ... the first eight months of a randomized controlled trial, patients ...
... , WASHINGTON, Aug. 6 Lung Cancer Alliance ... another $11.8 million of the $20 million lung cancer research ... Research Program (CDMRP). , , (Logo: ... The solicitation invited researchers to compete for $10.5 ...
Cached Medicine News:Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 2Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 3Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 4Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 5Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 6Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 7Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 8Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 9Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 10Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 11Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 12Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 13Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 14Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 15Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 16Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 17Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 18Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 2Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 3Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 4Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 5Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 6Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 7Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 8Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 9Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 10Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 11Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 12Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 13Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 14Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 15Health News:Marathon Health Expands Midwest Presence 2Health News:Cleveland Joins Navvis & Company 2Health News:Guided care reduces cost of health care for older persons with chronic conditions 2Health News:LCA Announces More Requests for Bids on Lung Cancer Research Programs Funded Through the Department of Defense 2
(Date:1/15/2014)... 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... developing its Symphony® CGM System as a non-invasive, ... Robert F. Doman , Executive Chairman and ... "TEN", Noble Financial Capital Markets, Tenth Annual Equity ... a corporate presentation to prospective corporate partners and ...
(Date:1/15/2014)... , Jan. 15, 2014  Valeant Pharmaceuticals International, ... announced that the applicable waiting period under the Hart-Scott-Rodino ... the previously announced tender offer by its indirect wholly-owned ... outstanding shares of common stock of Solta Medical, Inc. ... of $2.92 per share, net to the seller in ...
(Date:1/14/2014)... FRAMINGHAM, Mass. , Jan. 14, 2014 /PRNewswire/ ... HTWR ), a leading innovator of less ... the treatment of advanced heart failure, today announced ... of 2013 will be approximately $53 million, bringing ... "Our full-year revenue growth of 87% ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4
... Halozyme Therapeutics, Inc. (Nasdaq: HALO ... Insulin-PH20 (recombinant human insulin with rHuPH20) produced glycemic ... (mealtime) insulin analog. The overall safety and adverse ... and both treatments were well tolerated. Insulin-PH20 achieved ...
... HistoRx, Inc. (privately held), a diagnostics company, announced ... of clinical diagnostic assays based on AQUA® technology. ... specialized laboratory service provider, is launching NexCourse®(1) BCa ... assays based on quantitative immunohistochemistry.  NexCourse BCa by ...
Cached Medicine Technology:Halozyme's rHuPH20 With Recombinant Human Insulin Demonstrates Glycemic Control Comparable to Lispro 2Halozyme's rHuPH20 With Recombinant Human Insulin Demonstrates Glycemic Control Comparable to Lispro 3Halozyme's rHuPH20 With Recombinant Human Insulin Demonstrates Glycemic Control Comparable to Lispro 4Halozyme's rHuPH20 With Recombinant Human Insulin Demonstrates Glycemic Control Comparable to Lispro 5HistoRx Announces First Clinical Diagnostic Use of AQUA® Technology 2HistoRx Announces First Clinical Diagnostic Use of AQUA® Technology 3
... System supports approaches to Admitting/Discharge/Transfer ... record keeping functions using a ... facilities and cut across institutional ... community clinics, physician, agency, nursing ...
... Dairylands Clinical Information Management ... suite of integrated applications ... departments and automate administrative ... The applications allow organizations ...
... include a Patient Face Sheet, ... many as six custom tabs, ... information is important for you ... Import Manager utility lets you ...
... WEBeDoctor® Physician-office® is an ... physicians, (Solo practice, group ... to complete their normal ... It is a front ...
Medicine Products: